|Articles|September 1, 2012
- Pharmaceutical Executive-09-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - September 2012
Busting the Tape
Advertisement
Articles in this issue
about 13 years ago
Pharm Exec's 11th Annual Industry Auditabout 13 years ago
Patients Wade Into the Pricing Debateabout 13 years ago
The Endless Treadmill of End-of-Life Careabout 13 years ago
The Power of Patient Feedbackabout 13 years ago
The Payer C Change: From Customers to Competitorsabout 13 years ago
The Margin Callabout 13 years ago
Open Innovation in Pharma: Defining the DialogueNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Johnson and Johnson Reveals Plan to Separate Orthopaedics Business
2
The Most-Favored-Nation Policy: Outlook and Implications Beyond U.S.
3
The Evolving Landscape in Psychiatry: Challenges and Opportunities for Biopharma
4
Nabla Bio Enters $1 Billion Multi-Year Research Collaboration with Takeda
5
